INCY

Incyte Corp

Incyte Corp is a leading biopharmaceutical company that is dedicated to discovering, developing, and commercializing innovative medicines. With a mission to improve the lives of patients suffering from serious diseases, Incyte focuses on advancing scientific research and developing new therapies. The company's portfolio includes drugs for the treatment of cancer, inflammation, and autoimmune disorders. Its flagship product, Jakafi, is the first and only FDA-approved treatment for patients with polycythemia vera, a rare blood cancer. Incyte is also developing a pipeline of novel drugs that target key pathways involved in cancer and immune system regulation. The company is committed to advancing science and collaborating with partners to bring new treatments to patients in need.

Instrument specification for Incyte Corp

Name
Minimum order value
Description
Maximum order value
Transaction Step
Type
Trading Hours
Contract size / 1 lot
Deposit required
Value of 1 pip
Financial leverage
Minimal step
Long swap (daily)
Short sale NO
Short swap (daily)
Distance SL and TP 0
3-day swap (date)

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top